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Intraosseous Vascular
Access for Alert Patients
When iv access fails, IO access offers a rapid, safe, and effective alternative.

OVERVIEW: Nurses are often faced with the challenge of starting an iv line in a patient who is dehydrated,
has suffered trauma, or is in shock. Even the efforts of the most skilled clinician may fail, while valuable time
is lost. Intraosseous access is a rapid, safe, and effective route for delivering fluids and medications, and is
recommended by numerous professional and specialty organizations for both pediatric and adult patients.
Yet many clinicians remain unaware of the procedure. This article outlines the procedure and devices used,
describes support for use in the literature, and discusses various considerations and nursing implications.
Keywords: emergency care, intraosseous access, intraosseous infusion
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mma Jolley, a three-year-old girl, presented
to the ED with her parents after experiencing three days of fever, nausea, vomiting, and
diarrhea. (This case is a composite based on two
similar cases in our experience.) Emma was alert
but pale, with a central capillary refill time of three
to four seconds. Her weight was 15 kg (33 lbs.)
and her vital signs were as follows: temperature,
100.8°F (38.2°C); heart rate, 148 beats per minute; respiratory rate, 26 breaths per minute; and
blood pressure, 78/50 mmHg. The ED physician
assessed her and ordered typical laboratory tests
for an ill child, including complete blood count,
electrolyte levels, and blood cultures. Because she
was obviously dehydrated, an iv fluid bolus of
20 mL/kg of warmed normal saline was ordered.
Emma was clearly very ill and the staff knew she
could deteriorate quickly. The ED nurse made two
attempts to start an iv line without success. Emma
was not only dehydrated but also had nonvisible,
nonpalpable veins. A pediatric nurse specialist was
called to assist but was also unsuccessful. Despite the
nurses’ best efforts, the unsuccessful attempts to start
an iv line and waiting for the specialist’s arrival had
consumed valuable time, and now the patient’s stability was compromised. Eighty minutes after vital
signs were first assessed, her skin was beginning to
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mottle, her hypotension had worsened, and her heart
rate had increased to 170 beats per minute.
An immediate fluid bolus was required to prevent progression from compensated shock to decompensated shock. But there was one problem:
Emma was awake. Although her level of consciousness had decreased, she was still somewhat alert and
responsive. Intraosseous (IO) access—via the intraosseous vasculature—was the next alternative
route, but there were concerns. Could such access
be attempted on a patient who wasn’t unconscious?
Would the parents understand why a hole was going
to be drilled into the bone of their child’s leg? Would
the procedure be painful? The patient’s condition
was rapidly worsening. The decision was made to
immediately place an IO needle in the proximal tibia
using an IO power driver (see Figure 1), which was
the hospital’s standard method for establishing IO
vascular access. Although the hospital also had manual insertion devices, it was determined that placement using the power driver would be less traumatic,
especially for a semiconscious patient, as less manual
pressure is required for placement.
As this case suggests, nurses are often faced with
the challenge of starting an iv line in a dehydrated
patient whose veins are difficult to visualize. Gaining iv access can also be complex when the patient
ajnonline.com
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has suffered trauma or is in shock. Even the efforts
of the most skilled clinician may fail, while valuable
time is lost—and this may be compounded if the institution has no guideline limiting the number of iv
attempts that should be made before another route
is tried. It’s reasonable for nurses to consider the use
of IO access in patients who are awake and not in a
resuscitative state in order to prevent clinical deterioration.

WHAT IS INTRAOSSEOUS ACCESS?

The IO space includes the spongy interior of a
bone’s epiphyses and the medullary cavity of the diaphysis. This space contains thousands of tiny blood
vessels that rapidly absorb any fluids or medications
and transport these substances to the central circulation. Unlike peripheral veins, the IO space is unlikely
to collapse in response to shock, trauma, or dehydration (unless the bone itself is compromised). For this
reason it’s sometimes referred to as a “noncollapsible
vein.”1
Various methods of gaining access to the IO space
are available. Manual insertion devices (see Figures
2 and 3) permit the insertion of a hollow steel needle,
which has a removable trocar to prevent it from becoming plugged with bone fragments. The device
handle allows the clinician to push and twist the
needle through the periosteum. Manually inserted
needles are often used in younger pediatric patients
because a child’s bones are still soft enough to permit
easy placement; they are difficult, if not impossible,
to use on adolescents and adults, whose bones have
calcified. A second method involves using a springloaded mechanism (see Figure 4), which generates
enough direct force to drive a sharpened needle
into the medullary cavity. The third method involves using a power driver to drill the needle into
the IO space with a rotary motion. These last two
methods can be performed on pediatric and adult patients.
Watch a video demonstration of the placement of an IO needle in the proximal tibia using
an IO power driver at http://links.lww.com/AJN/
A50.
In pediatric patients, the preferred placement site is
the medial proximal tibia, approximately 1 to 2 cm
below the tibial tuberosity.2 Other possible placement
sites include the distal femur, the distal tibia directly
above the medial malleolus, and the humeral head;
and in adults, the sternum and distal radius.2 In adults,
ajn@wolterskluwer.com
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An example of a manual pediatric intraosseous needle insertion. A. The
needle is angled slightly away from the joint space or, as more recent
sources have recommended, perpendicular to the bone. B. A back-andforth “screwing” motion is used to insert the needle. (“Rocking” the needle
from side to side results in enlargement of the puncture site and extravasation of infused fluid.) C. Intramedullary placement is confirmed by aspirating
marrow. Reprinted with permission from King C, et al. Textbook of Pediatric
Emergency Procedures. 2nd ed. Philadelphia: Lippincott Williams and Wilkins;
2007.

the humeral head placement is becoming more commonplace; studies suggest that this site may offer superior flow rates and that pain there is better tolerated
by alert patients.3, 4 Each IO insertion device has been
approved by the U.S. Food and Drug Administration
for particular sites, and different institutions may have
specific protocols for placement sites. It’s important
for the clinician to be aware of these approvals and
protocols in order to ensure appropriate placement.
AJN ▼ November 2013
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Figure 1. The EZ-IO Intraosseous Infusion System power driver and
needles. Photo courtesy of the Vidacare Corporation.

Once the IO needle has been placed, it can be used
in the same manner as an iv catheter for delivering
drugs, fluids, and blood products. A correctly placed
IO catheter will sit firmly on the bone and will not
move. It’s often suggested that bone marrow be aspirated immediately after insertion to verify correct

HISTORY AND SUPPORT FOR USE

History. The use of IO access is not new. C. K.
Drinker, a physician at Harvard University, and colleagues first reported IO infusion in 1922, when
they inspected sternum circulation in small mammals and established that fluids infused into the bone
marrow were absorbed into the central circulation.5
(Indeed, current research suggests that fluids and
drugs administered via the IO route reach the central circulation as fast as those given via central venous catheters.6) During World War II, IO access
was widely used to resuscitate military patients who
were dying of hemorrhagic shock; but after the war
its use declined.1 In 1988, the American Heart Association (AHA) prompted renewed interest in IO
access by including it as standard in its pediatric advanced life support (PALS) guidelines. Since then, the
AHA has continued to recommend the use of IO access earlier in the care of critical patients. In 2005, the
AHA revised its guidelines to recommend IO access
whenever iv access can’t be quickly achieved in a critically ill pediatric or adult patient.7, 8
Support in the literature. Numerous studies in
adult patients have shown that IO needle insertion is
fast and effective.3, 9-13 In a study of adults undergoing resuscitation, Leidel and colleagues found that
IO cannulation was a significantly faster and more
successful method for establishing vascular access
than central venous catheterization.13 In another
study, Lamhaut and colleagues found that IO access
could be gained significantly faster than peripheral
iv access (mean time, 50 ± 9 seconds and 70 ± 30
seconds, respectively).14 And Paxton and colleagues

Manually inserted needles are often used in younger
pediatric patients because a child’s bones are still soft enough
to permit easy placement.
placement; but the withdrawal of marrow isn’t always attainable. And while the aspiration of bone
marrow contents signifies that the catheter is in the
marrow space, blood return might not occur even
with proper placement.2 With any IO catheter, it’s essential that caregivers monitor the site frequently for
extravasation, which is evidenced by swelling of the
surrounding tissues.
Because of the relatively dense structure of the IO
space, flow rates through an IO catheter are slower
than they would be through most peripheral iv catheters. Fluids often will not flow freely through the IO
needle. An iv pressure bag or pump can be used to
ensure adequate flow.
36
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compared three access methods—peripheral iv, central venous catheterization, and IO using a power
driver—and found that IO cannulation yielded significantly faster results and higher success rates.3
Similar findings have been reported in pediatric
patients. A study using an IO power driver to achieve
vascular access resulted in successful insertion and infusion in 94% of the young patients.15 Insertion time
was 10 seconds or less in 77% of the one-attempt
successful cases. Other pediatric studies have reported
first-attempt successful insertion rates of between 81%
and 100%.16, 17
Recommendations from professional associations. The AHA and the American Academy of
ajnonline.com

Figure 2. The Jamshidi Intraosseous Needle, a manual infusion device. Photo courtesy of CareFusion
Corporation or one of its subsidiaries, 2010. All rights
reserved.

 ediatrics recognize IO cannulation as a simple and
P
effective mode of establishing vascular access in pediatric and adult patients.18-20 They note that IO access
offers clinicians a rapid, safe, and effective route for
delivering fluids and medications. Current PALS recommendations include using IO access as the “initial vascular access attempted” in “circumstances
[such as] cardiac arrest or severe shock with severe
vasoconstriction” and when peripheral iv access
“cannot be readily obtained in a child with compensated or hypotensive shock.”18
Both the Emergency Nurses Association (ENA)
and the American Association of Critical-Care Nurses
(AACN) have endorsed an Infusion Nurses Society
(INS) position paper stating that “a qualified registered nurse may insert, maintain, and remove IO access devices. Intraosseous access should be considered
if iv access cannot be obtained, and substantial concern exists for increased morbidity or even mortality in the patient from not obtaining treatment.”21-23
And the American College of Emergency Physicians
(ACEP) has issued a statement recognizing the need
ajn@wolterskluwer.com

for alternative modes of vascular access in the ED, including IO access.24

CONSIDERATIONS AND POSSIBLE COMPLICATIONS

Serious complications related to the use of IO access
are rare.2 IO access should not be attempted on any
bone with a suspected fracture, nor in a bone in which
IO access was recently attempted (within the last 24 to
48 hours). Extravasation of fluids or medications can
result from movement or accidental dislodgment of
the needle or from repeated IO attempts at the same
site.25 These extravasated substances can be harmful
to tissues and may lead to the development of compartment syndrome.2, 25 Clinicians must be careful to
protect and reassess the patency of the insertion site
and monitor the patient for any signs of compartment
syndrome. The infused iv fluids swell the patient’s
muscle compartments and affect arterial and venous
blood flow. Because IO access requires the use of an
iv pressure bag or pump to overcome the inherent arterial pressure in the IO space,26 it’s vital that nurses
continue to monitor and reassess access sites for patency and signs of extravasation.
As with any iv insertion, there is a risk of infection, either at the insertion site or in the bone. The
same protocols and precautions used to prevent infections with peripheral iv access should also be used
with IO access. Reported instances of osteomyelitis
or IO site infections have been few. One review of 30
studies involving more than 4,000 patients found
that osteomyelitis occurred in fewer than 0.6% of IO
insertions.27 Study findings indicate that osteomyelitis
can be prevented if the IO needle is removed within
24 hours of insertion, which is a current standard of
care for IO access.1, 28, 29

Figure 3. The Cook Intraosseous Infusion Needle, a manual
infusion device. Permission for use granted by Cook Medical
Incorporated, Bloomington, IN.
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Figure 4. The B.I.G. (bone injection gun), a spring-loaded device.
Adult (blue) and pediatric (red) models are shown. Photo courtesy of PerSys Medical.

Pain. Any decision to use IO access must consider the patient’s ability to tolerate the procedure.
The pain of IO needle insertion, which stimulates
nociceptors in the skin and periosteum, is typically
no more than that of a peripheral iv stick.30 But the
infusion of fluids into the medullary space, which
contains many pressure-sensitive nerve fibers, can
cause more severe pain.4, 30 Fortunately, studies have
shown that pain can be controlled with the use of 2%
preservative-free lidocaine injected slowly through the
IO device.2, 4, 26
The use of IO lidocaine in children. Before administering lidocaine to pediatric patients, certain
factors should be considered. A history of nonfebrile
seizures in a patient should prompt the clinician to
weigh the potential benefits and risks of lidocaine
use. The drug is known to lower the seizure threshold and may increase the risk of seizure in children
with a history of seizure or acute seizure activity.31, 32
That said, the dosage recommended for use in the
pediatric IO space is well below the maximum,33 as
is the case for adults.4 Thus a history of seizure is a
consideration, but not a contraindication, for the use
of IO lidocaine. [The authors’ facility has developed
an IO lidocaine dosing chart; for more information,
contact the authors.]

CASE REVISITED

When the IO needle was inserted, Emma showed no
withdrawal reflex, and a pain score of 0 was noted
using the Face, Legs, Activity, Cry, and Consolability (FLACC) pain assessment scale.34 (The FLACC
scale evaluates pain in five categories for a possible
total score of 0 [no pain] to 10 [worst pain]). As the
initial flush was administered, the patient exhibited
38
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a pain score of 6 on the FLACC scale, grimacing
and drawing up her legs and arching her back. At
the time of treatment, the hospital had no guideline
for the use of IO lidocaine before the administration
of fluids via IO access to a conscious patient. Because of Emma’s critical state, there wasn’t time
for the staff to investigate appropriate IO lidocaine
dosing; it was imperative that the fluid boluses be
given quickly. The most significant pain appeared
to occur upon infusion of the initial iv flush and
seemed to decrease during administration of the
first fluid bolus. After this bolus, her pain score decreased to 2.
After receiving three boluses of 20 mL/kg warm
normal saline, Emma’s heart rate dropped to 110
beats per minute, her blood pressure returned to
within normal range, and her capillary refill time decreased to less than two seconds. Her respiratory rate
dropped to 20 breaths per minute and her temperature decreased to 100.4°F (38°C). She became more
alert and responsive. Although she required a 24-hour
hospitalization for observation, she recovered from
her dehydration with no long-lasting effects.

LOOKING AHEAD

Despite recommendations from numerous specialty
organizations, including the AHA, the ENA, the
AACN, the INS, and the ACEP, IO access remains
underutilized.35 A recent literature review found that
reasons for this include lack of awareness, lack of
guidelines, lack of proper training, and lack of proper
equipment.35 Nurses must be actively engaged in efforts to further the acceptance and use of IO access
devices. Such efforts are more likely to succeed when
a department has an “IO champion” who can support and train nursing staff, persuade physicians and
others who may be hesitant about using IO access,
and maintain staff competency in the use of the devices. It’s also essential that institutions develop protocols and guidelines for IO vascular access. At our

IO access should not be
attempted on any bone with a
suspected fracture.
hospital, the two similar cases prompted the development of a protocol for the administration of lidocaine to conscious patients who need pain control
during IO infusions. The experience also led to improvements in our processes for establishing access
in acutely ill patients. For example, clinicians monitor
time closely when attempting iv access in patients
ajnonline.com

who are deteriorating, and will attempt IO access
sooner. ▼
For five additional continuing nursing education articles on infusion therapy, go to www.
nursingcenter.com/ce.
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